Serpin Pharma, founded in Northern Virginia, USA, is a privately held biotech company focused on developing first-in-class anti-inflammatory and immune-modulating peptides. Their core mission is to create targeted therapeutics that enhance the body's natural immune response, reduce inflammation, and restore immune balance. The company's flagship product, SP16, is derived from a natural SERPIN protein and aims to address unmet medical needs in inflammatory, autoimmune, and infectious diseases.

Notable figures associated with Serpin Pharma include leading scientists and biotech experts who have significantly contributed to the field of immunology. The company has garnered attention from key investors in the biotech sector, supporting its innovative research and development efforts. Serpin Pharma's achievements include advancing SP16 through critical stages of development, positioning it as a promising therapeutic candidate. The overall impact of Serpin Pharma lies in its potential to revolutionize treatments for various inflammatory and autoimmune conditions, offering new hope for patients worldwide.